LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 47.83 | 770.25 | 6383 | 6223 | 1.0256 | 1.0169 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 50.05 | 770.25 | 6292 | 6629 | 0.9491 | 0.9666 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 50.05 | 770.25 | 6840 | 6629 | 1.0318 | 1.0202 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 52.27 | 770.25 | 6705 | 7058 | 0.9499 | 0.9681 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 52.27 | 770.25 | 7276 | 7058 | 1.0308 | 1.0190 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 54.49 | 770.25 | 7199 | 7555 | 0.9528 | 0.9709 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 54.49 | 770.25 | 7896 | 7555 | 1.0451 | 1.0269 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 56.71 | 770.25 | 7673 | 8001 | 0.9589 | 0.9753 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 56.71 | 770.25 | 8315 | 8001 | 1.0392 | 1.0229 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 58.94 | 770.25 | 8080 | 8444 | 0.9569 | 0.9746 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 58.94 | 770.25 | 8852 | 8444 | 1.0483 | 1.0275 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 61.16 | 770.25 | 8600 | 8892 | 0.9672 | 0.9812 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 61.16 | 770.25 | 9191 | 8892 | 1.0336 | 1.0188 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 63.39 | 770.25 | 8932 | 9326 | 0.9577 | 0.9761 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 63.39 | 770.25 | 9694 | 9326 | 1.0394 | 1.0216 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 65.61 | 770.25 | 9463 | 9736 | 0.9720 | 0.9845 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 65.61 | 770.25 | 10040 | 9736 | 1.0312 | 1.0169 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 67.83 | 770.25 | 9784 | 10078 | 0.9708 | 0.9841 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 67.83 | 770.25 | 10428 | 10078 | 1.0347 | 1.0185 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 70.05 | 770.25 | 10342 | 10413 | 0.9931 | 0.9963 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 70.05 | 770.25 | 10877 | 10413 | 1.0445 | 1.0233 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 72.27 | 770.25 | 10594 | 10730 | 0.9872 | 0.9933 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 72.27 | 770.25 | 11125 | 10730 | 1.0367 | 1.0191 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 74.50 | 770.25 | 10929 | 10991 | 0.9943 | 0.9970 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 74.50 | 770.25 | 11410 | 10991 | 1.0381 | 1.0196 | MN20160304_L02 | K13 |